AMED SCARDA「ワクチン開発のための世界トップレベル研究開発拠点の形成事業」合同シンポジウム

*Masahiro Nemoto¹, Masahiro Kiuchi¹, Kaori Tsuji¹, Tsuguko Tomita¹, Kiyoshi Hirahara¹ (1. Department of Immunology, Chiba University, Graduate School of Medicine (Japan))

*Kota Kokubo¹, Kiyoshi Hirahara¹, Masahiro Kiuchi¹, Kaori Tsuji¹, Yuri Sonobe¹, Rie Shinmi¹, Takahisa Hishiya¹, Chiaki Iwamura¹, Atsushi Onodera¹, Toshinori Nakayama¹ (1. Department of Immunology, Graduate School of Medicine, Chiba University (Japan))

*Takuya Koike^1,2,3,4, Wataru Ise^3,4,5, Takeshi Inoue^1,3, Tomohiro Kurosaki^2,3,4 (1. UTOPIA , The University of Tokyo (Japan), 2. IMS, RIKEN (Japan), 3. IFReC, Osaka University (Japan), 4. CiDER, Osaka University (Japan), 5. CAMaD, Osaka University (Japan))

*Ayana Sunami^1,2, Norihide Jo^2,3, Yoko Hamazaki^1,2,4 (1. Laboratory of Immunobiology, Graduate School of Medicine, Kyoto University (Japan), 2. Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University (Japan), 3. Alliance Laboratory for Advanced Medical Research, Graduate School of Medicine, Kyoto University (Japan), 4. Kyoto University Immunomonitoring Center (KIC) (Japan))

*Takumi Kawasaki¹, Moe Ikegawa¹ (1. National Research Center for the Control and Preventation of Infectious Diseases Nagasaki University (Japan))

*Mayuko Izumi¹, Yoshimitsu Nakanishi¹, Sujin Kang², Atsushi Kumanogoh¹ (1. Department of Respiratory Medicine and Clinical Immunology, Graduate School of medicine, Osaka University (Japan), 2. Laboratory of Immune Regulation, WPI-IFReC, Osaka University (Japan))

*Akari Suzuki¹, Matteo Guerrini¹, Anunya Opasawatchai¹, Kazuhiko Yamamoto¹ (1. Center for integrative medical science, RIKEN (Japan))

*David G Priest¹, Jonas N Sondergaard², James B Wing^1,2 (1. Human Immunology (Single Cell Immunology) Laboratory, Immunology Frontier Research Center, The University of Osaka (Japan), 2. Human Single Cell Immunology Team, CIDER, Osaka University (Japan))

*Kazuhiro Matsuo¹, Satoru Mizuno¹, Hiroto Takeuchi¹, Kensuke Takada¹ (1. Institute for Vaccine Research and Development, Hokkaido University (Japan))

*Yusuke Kasuga^1,3, Ryota Ouda¹, Masashi Watanabe², Xin Sun¹, Riko Izawa¹, Miki Kimura¹, Atsuki Takeishi^1,3, Tsutomu Tanaka^1,3, Shigetsugu Hatakeyama², Koichi Kobayashi^1,3 (1. Department of Immunology, Faculty of Medicine, Hokkaido University (Japan), 2. Department of Medical Chemistry, Faculty of Medicine, Hokkaido University (Japan), 3. Hokkaido University Institute for Vaccine Research and Development (Japan))

*Yuqing WU^1,2, Haruki SASA^1,2, NAREN TONGLEGA^1,2, Zhongwei Zhang^1,2, Mariko KITAJIMA³, Hayato ISHIKAWA³, Hiroshi KIYONO^1,2,4, Yosuke KURASHIMA^1,2,4 (1. Department of Innovative Medicine, Graduate School of Medicine, Institute for Advanced Academic Research/ Research Institute of Disaster Medicine, Chiba University, Chiba, Japan. (Japan), 2. Chiba University Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan. (Japan), 3. Laboratory of Middle Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Chiba University (Japan), 4. Division of Comparative Pathology and Medicine, Chiba University-University of California San Diego Center for Mucosal Immunology, Allergy and Vaccine (cMAV), School of Medicine, San Diego, CA, USA. (United States of America))

*Tomoya Sengiku¹, Masato Kubo^2,3, Shohei Hori¹, Ruka Setoguhi¹ (1. Graduate School of Pharmaceutical Sciences, The University of Tokyo (Japan), 2. Research Institute for Biomedical Science, Tokyo University of Science (Japan), 3. Research Center for Integrative Medical Science (IMS), RIKEN Yokohama Institute (Japan))

*Akane Kurosugi¹, Chiaki Iwamura¹, Kiyoshi Hirahara¹ (1. Department of Immunology, Graduate School of Medicine, Chiba University (Japan))

*Burcu Temizoz^1,2,3,4, Takayuki Shibahara^5,2, Shiori Egashira², Koji Hosomi⁶, Jonguk Park⁷, Naz Surucu¹³, Albin Bjork^18,19, Erdal Sag¹⁴, Takehiko Doi¹⁵, Rabia Miray Kisla Ekinci¹⁷, Sibel Balci¹⁷, Marjan A. Versnel¹⁹, Jun Kunisawa⁶, Masahiro Yamamoto⁸, Kouji Kobiyama^1,2,3,4, Peter D. Katsikis¹⁹, Cevayir Coban^9,3,4, Mayda Gursel¹⁶, Seza Ozen¹⁴, Sumiyuki Nishida⁵, Atsushi Kumanogoh^5,11,12,10, Ken J. Ishii^1,2,3,4 (1. Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan (Japan), 2. Laboratory of Mockup Vaccine, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan (Japan), 3. International Vaccine Design Center (VDesC), The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo, Japan (Japan), 4. The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo, Japan (Japan), 5. Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan (Japan), 6. Laboratory of Vaccine Materials, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan (Japan), 7. Laboratory of Bioinformatics, Artificial Intelligence Center for Health and Biomedical Research, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan (Japan), 8. Department of Immunoparasitology, Division of Infectious Disease, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan (Japan), 9. Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan (Japan), 10. Department of Immunopathology, WPI, Immunology Frontier Research Center (IFReC), Osaka University, Suita, Osaka, Japan (Japan), 11. Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, Suita, Osaka, Japan (Japan), 12. Center for Infectious Diseases for Education and Research (CiDER), Osaka University, Suita, Osaka, Japan (Japan), 13. Department of Biological Sciences, Middle East Technical University (METU), Ankara, Turkey (Turkey), 14. Department of Pediatric Rheumatology, Hacettepe University, Ankara, Turkey (Turkey), 15. Department of Pediatrics, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan (Japan), 16. Izmir Biomedicine and Genome Center, Izmir, Turkey (Turkey), 17. Department of Pediatric Rheumatology, Cukurova University, Adana, Turkey (Turkey), 18. Division of Rheumatology, Department of Medicine, Karolinska Institute, Karolinska University Hospital Solna, Stockholm, Sweden (Sweden), 19. Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands (Netherlands))

*Riho Saito¹, Tomohiko Okazaki², Hiroki Sugishita³, Yukiko Gotoh¹ (1. Graduate school of pharmaceutical sciences, University of Tokyo (Japan), 2. Institute for Genetic Medicine, Hokkaido University (Japan), 3. International Research Center for Neurointelligence (IRCN), The University of Tokyo (Japan))

*Ayumi Kuratani¹, Masahiro Yamamoto^1,2,3,4 (1. Department of Immunoparasitology, RIMD, Osaka University (Japan), 2. Laboratory of Immunoparasitology, IFReC, Osaka University (Japan), 3. CiDER, Osaka University (Japan), 4. CAMaD, Osaka University (Japan))

*Anunya Opasawatchai¹, Masahiro Nakano², Akari Suzuki¹, Kazuyoshi Ishigaki², Kazuhiko Yamamoto¹ (1. Laboratory for Autoimmune Diseases, RIKEN Center for Integrative Medical Sciences (Japan), 2. Laboratory for Human Immunogenetics,RIKEN Center for Integrative Medical Sciences (Japan))

*Taku Kureha¹, Ryunosuke Muro², Wang Suqi¹, Takeshi Nitta², Hiroshi Takayanagi¹ (1. The University of Tokyo (Japan), 2. Tokyo University of Science (Japan))

*Haruki Hirata^1,2,3, Yoshino Kawaguchi², Mari Kimura^2,4, Hiroki Tanaka^1,5, Toshiro Hirai^1,2,3,6, Hidetaka Akita^1,5, Taro Shimizu^1,2,6, Yasuo Yoshioka^{1,2,3,4,6,7,8} (1. Center for Advanced Modalities and DDS, Osaka University (Japan), 2. Research Institute for Microbial Diseases, Osaka University (Japan), 3. Graduate School of Pharmaceutical Sciences, Osaka University (Japan), 4. The Research Foundation for Microbial Diseases of Osaka University (Japan), 5. Graduate School of Pharmaceutical Sciences, Tohoku University (Japan), 6. Institute for Open and Transdisciplinary Research Initiatives, Osaka University (Japan), 7. Center for Infectious Disease Education and Research, Osaka University (Japan), 8. Global Center for Medical Engineering and Informatics, Osaka University (Japan))

*Kenichi Otaki¹, Fumihiro Yasui², Hirohito Ishigaki¹, Naoko Kitagawa¹, Michinori Kohara², Koji Ishii³, Yasushi Itoh¹ (1. Division of Pathogenesis and Disease Regulation, Department of Pathology, Shiga University of Medical Science (Japan), 2. Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science (Japan), 3. Department of Quality Assurance and Radiological Protection, National Institute of Infectious Diseases (Japan))

*Yohei Uchida¹, Rika Nakahashi^1,2, Shingo Umemoto^1,3, Hiroshi Kiyono^1,2,4,5,6,7 (1. Department of Human Mucosal Vaccinology, Chiba University Hospital (Japan), 2. Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Chiba University (Japan), 3. Department of Otorhinolaryngology and Head & Neck Surgery, Faculty of Medicine, Oita University (Japan), 4. Future Medicine Education and Research Organization, Chiba University (Japan), 5. Department of Medicine, UC San Diego School of Medicine (United States of America), 6. CU-UCSD Center for Mucosal Immunology, Allergy and Vaccines (cMAV), UC San Diego School of Medicine (United States of America), 7. Division of Infectious Disease Vaccine R&D, Research Institute of Disaster Medicine, Chiba University (Japan))

*Yuji Tsunekawa¹, Ken Sugo¹, Ysunari Matsuzaka¹, Hiromi KInoh¹, Hiroshi Ueki², Seiya Yamayoshi², Takashi Okada¹ (1. Institute of Medical Science, The University of Tokyo DMMG (Japan), 2. Institute of Medical Science, The University of Tokyo DV (Japan))

*Meito Shibuya^1,2, Risa Takahashi¹, Tomonori Machita¹, Tomoyuki Yamanoue¹, Satoshi Koike³, Kyousuke Kobayashi³, Seiya Yamayoshi^5,4, Hiroshi Kiyono^1,7, Kohtaro Fujihashi^1,6,8,9 (1. Department of Human Mucosal Vaccinology, Chiba University Hospital, and Chiba University Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Chiba University, Chiba (Japan), 2. Vaccine R&D Laboratory, Vaccine Business Division, Shionogi & Co., Ltd., Osaka (Japan), 3. Neurovirology Project, Department of Diseases & Infection, Tokyo Metropolitan Institute of Medical Science, Tokyo (Japan), 4. Div. Virology and Intern. Res. Ctr Infect. Dis., Inst. Med. Sci., and Univ. Tokyo Pandemic Prep., Infect. Adv. Res. Ctr (UTOPIA), The University of Tokyo, Tokyo (Japan), 5. The Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo (Japan), 6. Division of Infectious Disease Vaccine R&D, Research Institute of Disaster Medicine, Chiba University, Chiba (Japan), 7. Chiba University-University of California San Diego Center for Mucosal Immunology, Allergy and Vaccine (CU-UCSD cMAV), Department of Medicine, School of Medicine, San Diego, CA (United States of America), 8. Division of Mucosal Vaccines, International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo (Japan), 9. Department of Pediatric Dentistry, The University of Alabama at Birmingham, Birmingham AL (United States of America))

*Satoru Mizuno¹, Kensuke Takada¹, Hiroto Takeuchi¹, Kazuhiro Matsuo¹ (1. Institute for Vaccine Research and Development, Hokkaido University (Japan))

*Ryuta Uraki^1,2,3, Yoshihiro Kawaoka^1,2,3,4 (1. UTOPIA, The University of Tokyo (Japan), 2. Division of Virology, Institute of Medical Science, The University of Tokyo (Japan), 3. The Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute (Japan), 4. Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison (United States of America))

*Hiromi Mori¹ (1. Department of Human Mucosal Vaccinology, Chiba University Hospital (Japan))

*Farzaneh Valanezhad^1,2,3, Jalal Alshaweesh⁴, Shara Bakytbek^1,2,3, Sakiko Shimizu⁵, Ryo Tanaka⁵, Yoichiro Iwase⁵, Risa Nakamura^1,2,3, Greg Matlashewski⁶, Sreenivas Gannavaram⁷, Hira Nakhasi⁷, Abhay Satoskar⁸, Shinjiro Hamano^1,2,3 (1. Institute of Tropical Medicine, Nagasaki University (Japan), 2. Graduate School of Biomedical Sciences. Nagasaki University, Nagasaki (Japan), 3. The Vaccine Research and Development Center, DEJIMA Infectious Disease Research Alliance (DIDA), Nagasaki University, Nagasaki (Japan), 4. The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo (Japan), 5. TERUMO Corporation, Medical Care Solutions Company, Pharmaceutical Solutions Division, R&D (Japan), 6. Department of Microbiology and Immunology, McGill University, Montreal, QC (Canada), 7. Division of Emerging and Transfusion Transmitted Diseases, CBER, FDA, Silver Spring, MD, 20993 (United States of America), 8. Department of Pathology, The Ohio State University, Columbus, Ohio (United States of America))

*SHARA BAKYTBEK^1,2,3, Farzaneh Valanezhad^1,2,3, Ayako Hyuga^1,2,3, Shin-Ichi Inoue^2,4, Yui Katsuyuki⁵, Shusaku Mizukami^3,6, Risa Nakamura^1,2,3, Kazuhide Onoguchi⁷, Sebastian Kapell^8,9, Kouichi Morita^3,10, Shinjiro Hamano^1,2,3 (1. Department of Parasitology, Institute of Tropical Medicine (NEKKEN), The Joint Usage/Research Center on Tropical Disease, Nagasaki University, Nagasaki (Japan), 2. Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki (Japan), 3. The Vaccine Research and Development Center, DEJIMA Infectious Disease Research Alliance (DIDA), Nagasaki University, Nagasaki (Japan), 4. Department of Molecular Microbiology and Immunology, Division of Immunology, Nagasaki University, Nagasaki (Japan), 5. SHIONOGI Global Infectious Diseases Division Institute of Tropical Medicine, Nagasaki University, Nagasaki (Japan), 6. Department of Immune Regulations, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki (Japan), 7. AI Drug Development Division, NEC Corporation, Tokyo (Japan), 8. Department of Vaccine Informatics, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki (Japan), 9. NEC OncoImmunity AS, Ullernchausseen 64/66, 0379, Oslo (Norway), 10. Department of Virology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki (Japan))

*Yuichi Suzuki¹, Yusuke Sato¹, Hideyoshi Harashima¹ (1. Faculty of Pharmaceutical Sciences, The University of Hokkaido (Japan))

*Hiroshi Ueki^1,2,3, Maki Kiso¹, Shun Iida⁴, Tadaki Suzuki⁴, Yoshihiro Kawaoka^1,2,3,5 (1. Division of Virology, Institute of Medical Science, University of Tokyo (Japan), 2. The University of Tokyo, Pandemic Preparedness, Infection and Advanced Research Center (Japan), 3. Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute (Japan), 4. Department of Pathology, National Institute of Infectious Diseases (Japan), 5. Department of Pathobiological Sciences, University of Wisconsin-Madison (United States of America))

Moe KOBAYASHI¹, Nene KOBAYASHI¹, Kyoka DEGUCHI¹, Seira OMORI¹, *Takeshi ICHINOHE¹ (1. Institute of Medical Science, The University of Tokyo (Japan))

*Yoshinao Kubo¹, Manya Bakatumana Hans¹, Osamu Kotani², Hironori Sato², Koya Ariyoshi¹ (1. Institute of Tropical Medicine, Nagasaki University (Japan), 2. National Institute of Infectious Diseases (Japan))

Minato Hirano¹, *Kentaro YOSHII¹, Hirotaka Takahashi² (1. National Research Center for the Control and Prevention of Infectious Diseases,Nagasaki university (Japan), 2. Proteo-Science Center, Ehime University (Japan))

*Shusuke Kawakubo¹, Hiroaki Unno¹, Adam Strange¹, Spyros Lytras¹, Jumpei Ito¹, Kei Sato¹ (1. Institute of Medical Science, The University of Tokyo (Japan))

*Ryo Komorizono¹, Yuki Furuse¹ (1. UTOPIA, The University of Tokyo (Japan))

*Akihiko Sato^1,2,3, Shinji Kusakabe^1,3, Kei Konishi^1,3, Takao Shishido³, Michihito Sasaki^1,2, Yasuko Orba^1,2,4, Hirofumi Sawa^1,2,4 (1. International institute for Zoonosis Control,Hokkaido University (Japan), 2. Institute for Vaccine Research and Development, Hokkaido University (Japan), 3. Shionogi & Co. Ltd. (Japan), 4. One Health Research Center, Hokkaido University (Japan))

*Wakako Furuyama¹, Asuka Nanbo¹ (1. Nagasaki University (Japan))

*Cassia Sousa Moraes¹, Gabriel Gonzalez², Koshiro Tabata¹, Shinji Saito¹, Hirofumi Sawa¹, Yukari Itakura¹ (1. Division of Biological Response Analysis, IVReD, Hokkaido University (Japan), 2. Division of Research Support, IVReD, Hokkaido University (Japan))

*Sarunporn Tandhavanant^1,2, Hiroyuki Terashima^1,3, Hirotaka Hiyoshi¹, Dhira Saraswati Anggramukti⁴, Nopadol Precha^2,5, Tetsuya Iida⁴, Shigeaki Matsuda⁴, Narisara Chantratita², Toshio Kodama¹ (1. Institute of Tropical Medicine, Nagasaki University (Japan), 2. Faculty of Tropical Medicine, Mahidol University (Thailand), 3. College of Pharmacy, Kinjo Gakuin University (Japan), 4. Research Institute for Microbial Diseases, Osaka University (Japan), 5. School of Public Health, Walailak University (Thailand))

*Yuki Kanai¹, Norikazu Ichihashi¹, Atsushi Shibai², Naomi Yokoi², Saburo Tsuru¹, Chikara Furusawa^1,2 (1. The University of Tokyo (Japan), 2. RIKEN (Japan))

*Chukwuma Stephen Ezenwanne^1,2,3, Huai Chuang³, Taeko Naruse^1,2,3, Yuko Katakai⁴, Satoru Kawai⁵, Bruce Russell^3,6, Miako Sakaguchi⁷, Osamu Kaneko^1,2,3 (1. Graduate School of Biomedical Science, Nagasaki University, Nagasaki, Japan (Japan), 2. School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki (Japan), 3. Department of Protozoology, Institute of Tropical Medicine, Nagasaki University, Nagasaki (Japan), 4. The Corporation for Production and Research of Laboratory Primates, Ibaraki (Japan), 5. Department of Tropical Medicine and Parasitology, Dokkyo Medical University, Tochigi (Japan), 6. Department of Microbiology and Immunology, University of Otago (New Zealand), 7. Central Laboratory, Institute of Tropical Medicine, Nagasaki University, Nagasaki (Japan))

*Arata Hidano^1,6, Hannah R Holt¹, Sothyra Tum², Monidarin Chou³, Ty Chhay⁴, William Leung¹, PigFluCam+ Consortium^1,2,3,4,5, Yvonne Su⁵, Gavin JD Smith⁵, James W Rudge¹ (1. London School of Hygiene and Tropical Medicine (UK), 2. National Animal Health and Production Research Institute (Cambodia), 3. University of Health Sciences (Cambodia), 4. Livestock Development for Community Livelihood (Cambodia), 5. Duke-NUS Medical School (Singapore), 6. Nagasaki University (Japan))

*Yui Kimura^1,2, Kohei Uemura², Junki Mizusawa³, Taro Shibata³, Kousuke Kashiwabara¹ (1. Clinical Research Promotion Center, The University of Tokyo Hospital (Japan), 2. Department of Biostatistics & Bioinformatics, Interfaculty Initiative in Information Studies, The University of Tokyo (Japan), 3. Center for Research Administration & Support, National Cancer Center (Japan))

*Ito Ito Jumpei¹, Adam Strange¹, Wei Liu¹, Gustav Joas¹, Spyros Lytras¹, Kei Sato¹ (1. The Institute of Medical Science, The University of Tokyo (Japan))

*Yumiao Qiu^1,2, Keisuke Shimada¹, Kaito Yamamoto¹, Masahito Ikawa^1,2,3,4 (1. Research Institute for Microbial Diseases, Osaka university (Japan), 2. Graduate School of Medicine, Osaka university (Japan), 3. The Institute of Medical Science, The University of Tokyo (Japan), 4. Center for Infectious Disease Education and Research, Osaka university (Japan))

*Rika Hirano¹, Kazuto Yoshimi¹, Koji Asano¹, Kohei Takeshita², Ken J. Ishii¹, Kei Sato¹, Tomoji Mashimo¹ (1. Institute of Medical Science, The University of Tokyo (Japan), 2. RIKEN Spring-8 Center (Japan))

*Matteo Guerrini¹, Hiroaki Hatano^2,3, Akari Suzuki¹, Yasuhiro Murakawa⁴, Kazuyoshi Ishigaki^2,3, Kazuhiko Yamamoto¹ (1. Laboratory for Autoimmune Diseases, RIKEN Center for Integrative Medical Sciences (Japan), 2. Laboratory for Human Immunogenetics, RIKEN Center for Integrative Medical Sciences (Japan), 3. Department of Microbiology and Immunology, Keio University School of Medicine (Japan), 4. RIKEN-IFOM Joint Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences (Japan))

*Takafumi Ojima^1,2,3,4, Shinichi Namba^1,2,3, Ken Suzuki^1,2, Kenichi Yamamoto², Kyuto Sonehara^1,2,3, Akira Narita⁴, Yoichiro Kamatani¹, Gen Tamiya^3,4, Masayuki Yamamoto⁴, Toshimasa Yamauchi¹, Takashi Kadowaki⁵, Yukinori Okada^1,2,3 (1. The University of Tokyo (Japan), 2. Osaka University (Japan), 3. RIKEN (Japan), 4. Tohoku University (Japan), 5. Toranomon Hosipital (Japan))

*Yichen Jiang¹, Ayumu Tsubosaka¹, Miwako Kakiuchi¹, Daisuke Komura¹, Hiroto Katoh¹, Shumpei Ishikawa¹ (1. Department of Preventive Medicine, The University of Tokyo (Japan))

*Shinichi Namba^1,2,3, Masato Akiyama⁴, Haruka Hamanoue⁵, Kazuto Kato², Minae Kawashima⁶, Itaru Kushima⁷, Koichi Matsuda¹, Masahiro Nakatochi⁷, Soichi Ogishima⁸, Kyuto Sonehara^1,2,3, Ken Suzuki^1,2, Atsushi Takata⁹, Gen Tamiya^8,10, Chizu Tanikawa¹, Kenichi Yamamoto², Natsuko Yamamoto², Norio Ozaki⁷, Yukinori Okada^1,2,3 (1. The University of Tokyo (Japan), 2. Osaka University (Japan), 3. RIKEN Center for Integrative Medical Sciences (Japan), 4. Kyushu University (Japan), 5. Yokohama City University Hospital (Japan), 6. ROIS-DS (Japan), 7. Nagoya University (Japan), 8. Tohoku University (Japan), 9. RIKEN Center for Brain Science (Japan), 10. RIKEN Center for Advanced Intelligence Project (Japan))

*Ryuya Edahiro^1,2, Go Sato^1,2, Yuya Shirai^1,2, Tatsuhiko Naito^1,2, Kyuto Sonehara^1,2,3, Yoshihiko Tomofuji^1,2,3, Kenichi Yamamoto¹, Shinichi Namba^1,2,3, Noah Sasa¹, Genta Nagao^3,4, Ho Namkoong⁴, Koichi Fukunaga⁴, Takayoshi Morita¹, Yasuhirko Kato¹, Haruhiko Hirata¹, Yoshito Takeda¹, Daisuke Okuzaki⁵, Atsushi Kumanogoh^1,5, Yukinori Okada^1,2,3,5 (1. Osaka University Graduate School of Medicine (Japan), 2. RIKEN Center for Integrative Medical Sciences (Japan), 3. Graduate School of Medicine, the University of Tokyo (Japan), 4. Keio University School of Medicine (Japan), 5. Immunology Frontier Research Center (WPI-IFReC), Osaka University (Japan))

*YOSHINORI SAKATA¹, MIWAKO IWAI¹, TOMOKI TODO¹ (1. Division of Innovative Cancer Therapy, The Institute of Medical Science, The University of Tokyo (Japan))

*Hotaka Kobayashi^1,2,3 (1. IQB, The University of Tokyo (Japan), 2. IAMS, Tokushima University (Japan), 3. PRESTO, JST (Japan))

*Koji Hashimoto¹ (1. Graduate School of Arts and Sciences, The University of Tokyo (Japan))

*Hideyuki Nakanishi^1,2, Keiji Itaka^1,2 (1. Center for Infectious Disease Education and Research (CiDER), Osaka University (Japan), 2. Department of Biofunction Research, Laboratory for Biomaterials and Bioengineering, Institute of Integrated Research, Institute of Science Tokyo (Japan))

*Suzumi M Tokuoka¹, Fumie Hamano¹, Ayako Kobayashi¹, Yoshiya Oda¹ (1. The University of Tokyo (Japan))

*Shinji C. Nagasaki¹, Itaru Imayoshi^1,2,3 (1. Laboratory of Deconstruction of Stem Cells, Institute for Life and Medical Sciences (LiMe), Kyoto University (Japan), 2. Laboratory of Brain Development and Regeneration, Graduate School of Biostudies, Kyoto University (Japan), 3. Center for Living Systems Information Science, Graduate School of Biostudies, Kyoto University (Japan))

*Koshi Imami¹, Akari Suzuki¹, Takahiro Nishino^1,2, Hiroaki Hatano¹, Yoshihiko Tomofuji^1,6, Jun Seita¹, Kazuyoshi Ishigaki^1,2, Yukinori Okada^1,3,4,5,6, Kazuhiko Yamamoto¹ (1. Center for Integrative Medical Sciences, RIKEN (Japan), 2. Department of Microbiology and Immunology, Keio University School of Medicine (Japan), 3. Department of Statistical Genetics, Osaka University Graduate School of Medicine (Japan), 4. Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University (Japan), 5. Center for Infectious Disease Education and Research (CiDER), Osaka University (Japan), 6. Department of Genome Informatics, Graduate School of Medicine, The University of Tokyo (Japan))

*David Wang¹, Makoto Nakanishi¹ (1. Institute of Medical Science, The University of Tokyo (Japan))

*Shoko Sato¹, Mariko Dacher¹, Yoshimasa Takizawa¹, Hitoshi Kurumizaka¹ (1. Institute for Quantitative Biosciences, The University of Tokyo (Japan))

*Shunsuke Kita¹, Souta Kobayashi¹, Toshiki Sekiya², Naoki Nomura², Chimuka Handabile², Masashi Shingai², Hiroshi Kida², Katsumi Maenaka¹ (1. Hokkaido University, Faculty of Pharmaceutical Sciences (Japan), 2. Hokkaido University, Inter. Inst. Zoonosis Control (Japan))

*Toshifumi Morimura¹, Hideaki Tsuchiya¹, Chizuru Iwatani¹, Nao Maeda¹, Yuko Abiko¹, Eiichi Okamura¹, Masatsugu Ema¹ (1. Research Center for Animal Life Science, Shiga University of Medical Sceince (Japan))

*Yuichiro Higuchi¹, Shotaro Uehara¹, Nao Yoneda¹, Kazuhiro Murai², Akinori Takemura³, Seiichi Ishida⁴, Mina Ogawa⁵, Hiroshi Suemizu¹ (1. Liver Engineering Laboratory, Central Institute for Experimental Medicine and Life Science (Japan), 2. Osaka University (Japan), 3. Chiba University (Japan), 4. Sojo University (Japan), 5. Toronto University (Canada))

*Kenya Sato¹, Ryoji Ito¹, Mamoru Ito¹, Erika Sasaki¹ (1. Central Institute for Experimental Medicine and Life Science (Japan))

*Md Ariful Islam^1,2, Taslima Rahman Chowdhury^1,2, Hideyuki Nakanishi^1,3, Keiji Itaka^1,3, Satoshi Obika^1,2 (1. Center for Advanced Modalities and DDS, Osaka University (Japan), 2. Graduate School of Pharmaceutical Sciences, Osaka University (Japan), 3. Institute of Science Tokyo (Japan))

*Takahiro Nomoto¹, Daiki Tokura¹ (1. Graduate School of Arts and Sciences, The University of Tokyo (Japan))

*Tadahaya Mizuno¹, Iori Azuma¹, Takumi Iwasaka¹, Eri Nakashima¹, Hiroyuki Kusuhara¹ (1. Graduate School of Pharmaceutical Sciences, The University of Tokyo (Japan))

*Seohyun Lee¹, Hideaki Ota², Hideo Higuchi³, Takehiro Yamaguchi⁴, Ryoma Nakao⁴ (1. Interfaculty Initiative in Information Studies, The University of Tokyo (Japan), 2. Graduate School of Science, The University of Tokyo (Japan), 3. New Industry Creation Hatchery Center, Tohoku University (Japan), 4. National Institute of Infectious Diseases (Japan))

Kihoon Kim¹, *Ryo Matsunaga¹, Takanori Yokoo¹, Makoto Nakakido¹, Kouhei Tsumoto¹ (1. The University of Tokyo (Japan))

*Yuji Watanabe¹, Akiko Takahashi², Jin Higashijima³, Hiroshi Mizuuchi¹ (1. Chiba University, Synergy Institute for Futuristic Mucosal Vaccine Research and Development (Japan), 2. Artificial Intelligence Medicine, Graduate School of Medicine, Chiba University (Japan), 3. College of Liberal Arts and Sciences, Chiba University (Japan))

*Kazuma Handa¹, Masashi Kawamura¹, Masao Sasai¹, Takashi Matsuzaki², Akima Harada¹, Lisa Fujimura¹, Julia Whitehouse¹, Anri Fujishiro³, Kunio Hirano³, Kenji Miki⁴, Shigeru Miyagawa^1,4 (1. Department of Cardiovascular Surgery, Osaka University (Japan), 2. Department of DDS Pharmaceutical Development, Osaka University Graduate School of Medicine (Japan), 3. Terumo Corporation, Innovation Center, Kanagawa (Japan), 4. Premium Research Institute for Human Metaverse Medicine (WPI-PRIMe), Osaka University (Japan))

*Toshifumi Imagawa¹ (1. Graduate School of Biomedical Sciences, Nagasaki University (Japan))

*Junetsu Igarashi¹, Kimiyo Kamamoto-Shono¹, Akiko Takechi¹, Yoshihiro Takashima¹, Hideo Takasu¹, Yutaka Saisho¹, Noriko Tomita¹, Akira Kikuchi², Yoshiya Hosokawa², Takayuki Yoshioka¹ (1. Center for Advanced Modalities and Drug Delivery Systems (CAMaD) (Japan), 2. Center for Infectious Disease Education and Research (CiDER) (Japan))

*Tomoya Hayashi^1,2,3, Shuntaro Shimizu^1,2,3, Koji Sakamoto⁴, Naozumi Hashimoto⁵, Kouji Kobiyama^1,2,3, Hideo Negishi^1,2,3, Burcu Temizoz^1,2,3, Cevayir Coban^1,2,3, Ken J Ishii^1,2,3 (1. The Institute of Medical Science, The University of Tokyo (IMSUT) (Japan), 2. International Vaccine Design Center, IMSUT (Japan), 3. The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA) (Japan), 4. Department of Respiratory Medicine, Nagoya University Graduate School of Medicine (Japan), 5. Department of Respiratory Medicine, Fujita Health University (Japan))

*KAZUO SATO¹ (1. AMED SCARDA (Japan))